Beijing Tongrentang Co Ltd (600085) - Total Liabilities
Based on the latest financial reports, Beijing Tongrentang Co Ltd (600085) has total liabilities worth CN¥8.79 Billion CNY (≈ $1.29 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Beijing Tongrentang Co Ltd to see how much of total assets are deployed in long-term investments.
Beijing Tongrentang Co Ltd - Total Liabilities Trend (1994–2025)
This chart illustrates how Beijing Tongrentang Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Beijing Tongrentang Co Ltd (600085) total assets.
Beijing Tongrentang Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Tongrentang Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ViTrox Corporation Bhd
KLSE:0097
|
Malaysia | RM482.53 Million |
|
Big Shopping Centers Ltd
TA:BIG
|
Israel | ILA29.56 Billion |
|
Patanjali Foods Limited
NSE:PATANJALI
|
India | Rs55.88 Billion |
|
Chartwell Retirement Residences
TO:CSH-UN
|
Canada | CA$3.33 Billion |
|
Shanghai Fudan Microelectronics Group Co Ltd
SHG:688385
|
China | CN¥2.48 Billion |
|
COWAY Co. Ltd
KO:021240
|
Korea | ₩3.96 Trillion |
|
AAR Corp
NYSE:AIR
|
USA | $1.65 Billion |
|
RTL Group SA
F:RRTL
|
Germany | €5.40 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Beijing Tongrentang Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Beijing Tongrentang Co Ltd (600085) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Tongrentang Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Tongrentang Co Ltd (1994–2025)
The table below shows the annual total liabilities of Beijing Tongrentang Co Ltd from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥9.24 Billion ≈ $1.35 Billion |
-10.24% |
| 2024-12-31 | CN¥10.30 Billion ≈ $1.51 Billion |
+4.72% |
| 2023-12-31 | CN¥9.83 Billion ≈ $1.44 Billion |
+14.46% |
| 2022-12-31 | CN¥8.59 Billion ≈ $1.26 Billion |
+2.26% |
| 2021-12-31 | CN¥8.40 Billion ≈ $1.23 Billion |
+33.53% |
| 2020-12-31 | CN¥6.29 Billion ≈ $920.59 Million |
+0.47% |
| 2019-12-31 | CN¥6.26 Billion ≈ $916.27 Million |
+5.27% |
| 2018-12-31 | CN¥5.95 Billion ≈ $870.42 Million |
+7.37% |
| 2017-12-31 | CN¥5.54 Billion ≈ $810.68 Million |
+11.21% |
| 2016-12-31 | CN¥4.98 Billion ≈ $728.98 Million |
+43.59% |
| 2015-12-31 | CN¥3.47 Billion ≈ $507.69 Million |
-19.32% |
| 2014-12-31 | CN¥4.30 Billion ≈ $629.26 Million |
+5.54% |
| 2013-12-31 | CN¥4.07 Billion ≈ $596.23 Million |
+0.27% |
| 2012-12-31 | CN¥4.06 Billion ≈ $594.62 Million |
+61.33% |
| 2011-12-31 | CN¥2.52 Billion ≈ $368.59 Million |
+98.64% |
| 2010-12-31 | CN¥1.27 Billion ≈ $185.55 Million |
+25.63% |
| 2009-12-31 | CN¥1.01 Billion ≈ $147.69 Million |
+15.74% |
| 2008-12-31 | CN¥872.09 Million ≈ $127.61 Million |
+7.09% |
| 2007-12-31 | CN¥814.33 Million ≈ $119.16 Million |
-5.57% |
| 2006-12-31 | CN¥862.40 Million ≈ $126.20 Million |
-5.82% |
| 2005-12-31 | CN¥915.65 Million ≈ $133.99 Million |
-4.31% |
| 2004-12-31 | CN¥956.91 Million ≈ $140.03 Million |
+28.12% |
| 2003-12-31 | CN¥746.90 Million ≈ $109.29 Million |
-7.44% |
| 2002-12-31 | CN¥806.96 Million ≈ $118.08 Million |
+14.58% |
| 2001-12-31 | CN¥704.27 Million ≈ $103.06 Million |
+28.41% |
| 2000-12-31 | CN¥548.45 Million ≈ $80.26 Million |
+26.29% |
| 1999-12-31 | CN¥434.28 Million ≈ $63.55 Million |
+2.28% |
| 1998-12-31 | CN¥424.58 Million ≈ $62.13 Million |
+7.90% |
| 1997-12-31 | CN¥393.50 Million ≈ $57.58 Million |
-7.07% |
| 1996-12-31 | CN¥423.41 Million ≈ $61.96 Million |
-4.43% |
| 1995-12-31 | CN¥443.04 Million ≈ $64.83 Million |
-3.33% |
| 1994-12-31 | CN¥458.28 Million ≈ $67.06 Million |
-- |
About Beijing Tongrentang Co Ltd
Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, … Read more